MSR16 Mixture-Cure Modelling of Overall Survival of Patients with Metastatic Non-Small Cell Lung Cancer Receiving Nivolumab + Ipilimumab in CheckMate 277 – Updated with 5 Years of Follow-up
VALUE IN HEALTH（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined